Skip to content
healthcare.dev

Lubiprostone

NDC 70771-1764, Lubiprostone, capsule, from Zydus Lifesciences Limited.

Product NDC
70771-1764
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214131
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1764 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUBIPROSTONE24 ug/1

Pharmacologic classes

Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]

Package NDCNDC-11Package
70771-1764-170771176401100 CAPSULE in 1 BOTTLE (70771-1764-1)
70771-1764-67077117640660 CAPSULE in 1 BOTTLE (70771-1764-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/81f9c9de-f89d-4ab0-a8ca-18d3691e42f9

Use it

Look up 70771-1764 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1764 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1764. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.